When a publicly-traded MedTech company's new leadership anticipates a storm, the first asset they must engineer is a new narrative. This was the reality for Hydromer in early 2024. Despite a strong Q1, the leadership team knew that deep-seated structural issues would lead to a significant annual decline. Their mandate was to architect a new investment thesis - a foundational blueprint for renewal that could restore long-term investor confidence and secure a mandate for the difficult changes required to turn the company around.

Client Profile

Hydromer is a publicly traded MedTech company specializing in advanced polymer and coating technologies for healthcare, biotech, and industrial applications. With a legacy spanning decades, Hydromer built its reputation as a pioneer in biocompatible solutions, but in recent years the company faced mounting pressures to restore profitability and redefine its market position.

The High-Stakes Challenge: Architecting a Narrative to Navigate a Turnaround

In early 2024, Hydromer's new leadership faced a strategic paradox. While their initial efforts produced a strong Q1, they knew the company's deep-seated issues - "legacy program attrition" and a historically under-resourced R&D pipeline - would lead to significant declines in the coming quarters, a trend that would ultimately contribute to a 12% annual revenue decline for the fiscal year.

For Hydromer, reversing the decline would require more than operational fixes - it demanded a new story capable of convincing investors that growth was still possible. Their mandate was clear and urgent: architect a new, forward-looking investment thesis to navigate the coming storm, restore long-term investor trust, and secure a mandate for the fundamental changes required for renewal.

The Architectural Process: Building a New Investment Thesis

Presentation Studio was engaged to architect the corporate-level narrative that would reposition Hydromer for growth. Our process included:

• Diagnostic Deconstruction: We analyzed financial performance, competitive pressures, and leadership's strategic priorities to identify the levers of renewal.
• Investment Thesis Architecture: We reframed the story from a defense of past performance into a forward-looking blueprint centered on growth markets, new product pipelines, and operational efficiency.
• Narrative Engineering: The resulting corporate deck was designed not as a presentation, but as the tangible proof of transformation - a high-stakes communication asset capable of restoring investor confidence.
• Boardroom Readiness: The materials were structured for maximum clarity under scrutiny, ensuring that Hydromer's leadership could deliver the message with conviction and credibility.

The Outcome

The narrative we engineered became the cornerstone of Hydromer's new corporate strategy, equipping leadership with the foundational asset they needed to lead through the turnaround:

• A Blueprint for Renewal: The new corporate story provided the strategic clarity and mandate for leadership to execute difficult but necessary changes, including the complete restructuring of their R&D division in October 2024.
• Renewed Investor Confidence: The investment thesis gave stakeholders a clear, evidence-based rationale for supporting the long-term turnaround, even as the company navigated the challenging financial results of mid-2024.
• A Foundation for Growth: The narrative became the foundation for all ongoing strategic communications, guiding leadership in boardrooms, investor meetings, and market-facing engagements as they worked to reverse the company's trajectory.

This case study stands as proof that a well-architected narrative can do more than communicate strategy - it can create it.

---